Cargando…
Lister strain vaccinia virus, a potential therapeutic vector targeting hypoxic tumours
Hypoxia contributes to the aggressive and treatment-resistant phenotype of pancreatic ductal adenocarcinoma (PDAC). Oncolytic vaccinia virus has potential as an anti-tumour agent but the ability to lyse hypoxic tumour cells is vital for clinical efficacy. We hypothesised that unique aspects of the p...
Autores principales: | Hiley, Crispin T, Yuang, Ming, Lemoine, Nick R, Wang, Yaohe |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2875103/ https://www.ncbi.nlm.nih.gov/pubmed/19890355 http://dx.doi.org/10.1038/gt.2009.132 |
Ejemplares similares
-
Lister strain of vaccinia virus armed with endostatin-angiostatin fusion gene as a novel therapeutic agent for human pancreatic cancer
por: Tysome, James R, et al.
Publicado: (2009) -
Features of the Antitumor Effect of Vaccinia Virus Lister Strain
por: Zonov, Evgeniy, et al.
Publicado: (2016) -
Transient Inhibition of PI3Kδ Enhances the Therapeutic Effect of Intravenous Delivery of Oncolytic Vaccinia Virus
por: Ferguson, Mark S., et al.
Publicado: (2020) -
A marker-free system for highly efficient construction of vaccinia virus vectors using CRISPR Cas9
por: Yuan, Ming, et al.
Publicado: (2015) -
Genome Sequence of Vaccinia virus Strain Lister-Butantan, a Lister Vaccine Variant Used during a Smallpox Eradication Campaign in Brazil
por: Assis, Felipe, et al.
Publicado: (2016)